Beigene, Ltd.'s main business is research, development, production and commercialization of innovative drugs. The company's main products are Baiyueze, Baizean, Baihuize, Angavir, Belitor, Kailos, Savinco, Kaiser Bai, Pubexi (a biosimilar of Avaserelin), Baituowei (goserelin microspheres for injection), Tafina (dalafenib), Mejining (trametinib), Viquant (pazopanib), Fenito (everolimus), Zancoda (ceritinib). As of the end of the reporting period, the invention patents owned by the company and its holding subsidiaries include 64 invention patents in the United States, 67 invention patents in China, 30 invention patents in Japan, 15 invention patents in Europe and 135 invention patents in other countries or regions.
